Phase2, Single Group, Open Clinical Trial to Evaluate the Efficacy and Safety of Roflumilast in Symptomatic Bronchiectasis Patients
This study is not yet open for participant recruitment.
Verified April 2012 by Seoul National University Bundang Hospital
Sponsor:
Seoul National University Bundang Hospital
Information provided by (Responsible Party):
Hoil Yoon, Seoul National University Bundang Hospital
ClinicalTrials.gov Identifier:
NCT01580748
First received: April 18, 2012
Last updated: NA
Last verified: April 2012
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | January 2013 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |